Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
7.26
+0.48 (7.08%)
At close: Apr 24, 2026, 4:00 PM EDT
7.29
+0.03 (0.41%)
After-hours: Apr 24, 2026, 7:56 PM EDT
Edesa Biotech Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
64.51M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | - | - | - |
| Sep 30, 2024 | - | - | - |
| Sep 30, 2023 | - | - | - |
| Sep 30, 2022 | - | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionEDSA News
- 24 days ago - Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit - GlobeNewsWire
- 4 weeks ago - Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment - GlobeNewsWire
- 2 months ago - Edesa Biotech Reports Additional Positive Results from Phase 3 Paridiprubart Study - GlobeNewsWire
- 2 months ago - Edesa Biotech Reports Fiscal 1st Quarter 2026 Results - GlobeNewsWire
- 4 months ago - Edesa Biotech Reports Fiscal Year 2025 Results - GlobeNewsWire
- 6 months ago - Edesa Biotech Announces Upcoming Conference Schedule - GlobeNewsWire
- 6 months ago - Edesa Biotech Reports Positive Results in Phase 3 Respiratory Study - GlobeNewsWire
- 9 months ago - Edesa Biotech Reports Fiscal 3rd Quarter 2025 Results - GlobeNewsWire